What the research found

The piece draws on observed patterns among high-performing professionals rather than reporting specific new research. The primary evidence cited is a large observational study of over 122,000 people showing that cardiorespiratory fitness (measured as VO2 max) emerged as a stronger predictor of mortality risk than several established risk factors including smoking, diabetes, and hypertension. The framing suggests that low fitness carried roughly five times the mortality risk of high fitness in that cohort.

The text also references established neurobiology: that exercise—particularly resistance training and cardiovascular work—triggers molecular cascades that cross the blood-brain barrier and support neuronal growth and survival, with implications for cognitive aging.

Why it matters for you

If you're tracking biomarkers on MyKine, VO2 max belongs in that conversation alongside your lipid panel and inflammatory markers. Unlike many blood tests, it's a functional measure that predicts outcome, not just correlation. You can estimate it through field tests (like a max effort rowing piece or running protocol) or measure it directly via metabolic testing at a sports science lab. It's worth establishing a baseline and re-testing annually—not for vanity, but because the signal is unusually strong.

The second insight is about systematising what you already know works. If you're running a training protocol, you don't need it to feel effortful each session. Design friction out: train at the same time daily, co-locate it with something you already do (social time, commute), or remove the decision entirely by pre-committing with someone else. This applies whether you're doing strength work, conditioning, or any protocol where consistency compounds.

The neuroscience angle reframes training beyond aesthetics or performance metrics—it's literally maintaining your cognitive edge as you age, which matters if you're tracking biomarkers because you care about longevity and function.

Caveats

  • Observational, not causal: The mortality data on VO2 max doesn't prove fitness causes longer life, only that it correlates with it. Healthier baseline biology may drive both fitness capacity and survival.
  • Cherry-picked anecdote: One investor's habits aren't a study; they're pattern-spotting from a small, non-representative sample (wealthy, driven individuals).
  • No new mechanistic data: The neuroscience claims about exercise are well-established but presented without recent citations or nuance about effect sizes.
  • Selection bias: High-performers likely self-select for discipline; unclear how much of their success comes from training vs. pre-existing traits that also drive fitness consistency.